دورية أكاديمية

Influence of low-dose aspirin, resistance exercise, and sex on human skeletal muscle PGE 2 /COX pathway activity.

التفاصيل البيبلوغرافية
العنوان: Influence of low-dose aspirin, resistance exercise, and sex on human skeletal muscle PGE 2 /COX pathway activity.
المؤلفون: Naruse M; Human Performance Laboratory, Ball State University, Muncie, IN, USA., Fountain WA; Human Performance Laboratory, Ball State University, Muncie, IN, USA., Claiborne A; Human Performance Laboratory, Ball State University, Muncie, IN, USA., Chambers TL; Human Performance Laboratory, Ball State University, Muncie, IN, USA., Jones AM; Human Performance Laboratory, Ball State University, Muncie, IN, USA., Stroh AM; Human Performance Laboratory, Ball State University, Muncie, IN, USA., Montenegro CF; Human Performance Laboratory, Ball State University, Muncie, IN, USA., Lynch CE; Human Performance Laboratory, Ball State University, Muncie, IN, USA., Minchev K; Human Performance Laboratory, Ball State University, Muncie, IN, USA., Trappe S; Human Performance Laboratory, Ball State University, Muncie, IN, USA., Trappe TA; Human Performance Laboratory, Ball State University, Muncie, IN, USA.
المصدر: Physiological reports [Physiol Rep] 2021 Mar; Vol. 9 (5), pp. e14790.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society Country of Publication: United States NLM ID: 101607800 Publication Model: Print Cited Medium: Internet ISSN: 2051-817X (Electronic) Linking ISSN: 2051817X NLM ISO Abbreviation: Physiol Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Malden MA] : published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society, 2013-
مواضيع طبية MeSH: Sex Factors*, Adaptation, Physiological/*drug effects , Aspirin/*pharmacology , Exercise/*physiology , Muscle, Skeletal/*drug effects, Adaptation, Physiological/physiology ; Adipogenesis/drug effects ; Cyclooxygenase 2/metabolism ; Cyclooxygenase Inhibitors/pharmacology ; Humans ; Muscle, Skeletal/metabolism ; Quadriceps Muscle/drug effects ; Quadriceps Muscle/metabolism
مستخلص: Prostaglandin (PG) E 2  has been linked to increased inflammation and attenuated resistance exercise adaptations in skeletal muscle. Nonaspirin cyclooxygenase (COX) inhibitors have been shown to reduce these effects. This study examined the effect of low-dose aspirin on skeletal muscle COX production of PGE 2 at rest and following resistance exercise. Skeletal muscle (vastus lateralis) biopsies were taken from six individuals (4 M/2 W) before and 3.5 hr after a single bout of resistance exercise for ex vivo PGE 2 production under control and low (10 μM)- or standard (100 μM)-dose aspirin conditions. Sex-specific effects of aspirin were also examined by combining the current findings with our previous similar ex vivo skeletal muscle investigations (n = 20, 10 M/10 W). Low-dose aspirin inhibited skeletal muscle PGE 2 production (p < 0.05). This inhibition was similar to standard-dose aspirin (p > 0.05) and was not influenced by resistance exercise (p > 0.05) (overall effect: -18 ± 5%). Men and women had similar uninhibited skeletal muscle PGE 2 production at rest (men: 1.97 ± 0.33, women: 1.96 ± 0.29 pg/mg wet weight/min; p > 0.05). However, skeletal muscle of men was 60% more sensitive to aspirin inhibition than women (p < 0.05). In summary, the current findings 1) confirm low-dose aspirin inhibits the PGE 2 /COX pathway in human skeletal muscle, 2) show that resistance exercise does not alter aspirin inhibitory efficacy, and 3) suggest the skeletal muscle of men and women could respond differently to long-term consumption of low-dose aspirin, one of the most common chronically consumed drugs in the world.
(© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.)
References: BMC Musculoskelet Disord. 2011 Dec 30;12:292. (PMID: 22208783)
J Thromb Haemost. 2005 Apr;3(4):665-9. (PMID: 15703034)
J Physiol. 2016 Sep 15;594(18):5081-92. (PMID: 26893258)
J Biol Chem. 1982 Feb 25;257(4):1632-8. (PMID: 6799511)
Cell Metab. 2013 Feb 5;17(2):162-84. (PMID: 23395166)
Pharmacol Rev. 2004 Sep;56(3):387-437. (PMID: 15317910)
J Appl Physiol (1985). 2008 Feb;104(2):534-7. (PMID: 18079272)
Prostaglandins Leukot Essent Fatty Acids. 2013 May;88(5):361-4. (PMID: 23490068)
J Pharm Pharmacol. 1958 Jun;10(6):363-9. (PMID: 13550076)
Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):6675-6684. (PMID: 28607093)
Chem Rev. 2011 Oct 12;111(10):5821-65. (PMID: 21942677)
Prev Med Rep. 2016 Dec 28;5:183-186. (PMID: 28070474)
Clin Pharmacol Ther. 1982 Jan;31(1):30-7. (PMID: 7053301)
Compr Physiol. 2012 Oct;2(4):2829-70. (PMID: 23720267)
Am Heart J. 2007 Feb;153(2):175-81. (PMID: 17239674)
Arch Biochem Biophys. 2010 Jan 1;493(1):103-24. (PMID: 19728984)
Cell. 2020 Jun 25;181(7):1464-1474. (PMID: 32589957)
J Clin Endocrinol Metab. 2001 Oct;86(10):5067-70. (PMID: 11600586)
Am J Physiol Regul Integr Comp Physiol. 2013 Jul 1;305(1):R24-30. (PMID: 23637134)
Acta Physiol Scand. 2001 Jan;171(1):71-6. (PMID: 11350265)
Biol Sex Differ. 2020 Jun 5;11(1):32. (PMID: 32503637)
J Appl Physiol (1985). 2016 Mar 1;120(5):546-51. (PMID: 26607246)
J Appl Physiol (1985). 2017 Dec 1;123(6):1610-1616. (PMID: 28706001)
Am J Physiol Regul Integr Comp Physiol. 2013 Feb;304(3):R198-205. (PMID: 23220477)
Physiol Rep. 2019 Aug;7(13):e14108. (PMID: 31257737)
J Physiol. 2009 Nov 15;587(Pt 22):5483-92. (PMID: 19752122)
Thromb Res. 1981 Oct 1-15;24(1-2):163-8. (PMID: 7330835)
Br J Clin Pharmacol. 1985 May;19(5):675-84. (PMID: 4005105)
Am J Physiol Endocrinol Metab. 2002 Mar;282(3):E551-6. (PMID: 11832356)
J Appl Physiol (1985). 2020 Dec 1;129(6):1493-1504. (PMID: 33054657)
Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):43-50. (PMID: 23723142)
Biochem J. 1982 Apr 15;204(1):3-16. (PMID: 6810878)
J Physiol. 2002 Sep 1;543(Pt 2):691-8. (PMID: 12205200)
Br J Clin Pharmacol. 1986 Aug;22(2):135-42. (PMID: 3756063)
J Appl Physiol (1985). 2013 Sep;115(6):909-19. (PMID: 23539318)
Am J Physiol Cell Physiol. 2010 Jun;298(6):C1445-56. (PMID: 20457835)
Am J Physiol Regul Integr Comp Physiol. 2011 Mar;300(3):R655-62. (PMID: 21160058)
JAMA. 2018 Nov 20;320(19):2020-2028. (PMID: 30418471)
J Am Med Dir Assoc. 2013 Aug;14(8):626.e9-13. (PMID: 23747142)
J Appl Physiol (1985). 2020 Dec 1;129(6):1477-1482. (PMID: 33002382)
J Gerontol A Biol Sci Med Sci. 2016 Oct;71(10):1289-94. (PMID: 26817469)
Scand J Clin Lab Invest. 1962;14:59-65. (PMID: 13892924)
Nat Rev Rheumatol. 2014 May;10(5):295-303. (PMID: 24468934)
J Neurochem. 2001 Dec;79(5):950-8. (PMID: 11739606)
Ann Intern Med. 2019 Oct 15;171(8):596-598. (PMID: 31330542)
Nature. 1972 Sep 8;239(5367):102-3. (PMID: 4562107)
Nat Rev Drug Discov. 2002 Jan;1(1):37-44. (PMID: 12119608)
Scand J Med Sci Sports. 2010 Feb;20(1):e195-207. (PMID: 19522751)
J Appl Physiol (1985). 2020 Jan 1;128(1):87-99. (PMID: 31751180)
Am J Physiol Gastrointest Liver Physiol. 2000 Nov;279(5):G1113-20. (PMID: 11053009)
Cancer Epidemiol Biomarkers Prev. 2002 Mar;11(3):275-9. (PMID: 11895877)
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2771-5. (PMID: 3085105)
Prostaglandins Leukot Essent Fatty Acids. 2001 Apr-May;64(4-5):259-63. (PMID: 11418021)
Prostaglandins Leukot Essent Fatty Acids. 2006 Mar;74(3):175-81. (PMID: 16520030)
J Biol Chem. 2019 Feb 1;294(5):1697-1705. (PMID: 30710016)
J Gerontol A Biol Sci Med Sci. 2009 Nov;64(11):1183-9. (PMID: 19622801)
Annu Rev Pharmacol Toxicol. 2011;51:45-73. (PMID: 20854171)
معلومات مُعتمدة: U01AR071133 United States AR NIAMS NIH HHS
فهرسة مساهمة: Keywords: cyclooxygenase; low-dose aspirin; prostaglandin E2; resistance exercise; skeletal muscle
المشرفين على المادة: 0 (Cyclooxygenase Inhibitors)
EC 1.14.99.1 (Cyclooxygenase 2)
R16CO5Y76E (Aspirin)
تواريخ الأحداث: Date Created: 20210304 Date Completed: 20211220 Latest Revision: 20230919
رمز التحديث: 20230919
مُعرف محوري في PubMed: PMC7931802
DOI: 10.14814/phy2.14790
PMID: 33661544
قاعدة البيانات: MEDLINE
الوصف
تدمد:2051-817X
DOI:10.14814/phy2.14790